Self-testing at home kits cut waiting time and ease pressure on health services, 2San says

By Liza Laws

- Last updated on GMT

© Getty Images
© Getty Images
Diagnostic and digital tools company, 2San, has been listed with LLoydsPharmacy to offer seven health tests customers can do at home.

The company says self-diagnostic testing at home is becoming increasingly popular and say it can help facilitate better disease diagnosis, monitoring, and management. They also said that results can be produced far quicker because the kits cut out appointments and having to send the tests away to get the results.

The company believes as well as allowing people to do the tests in their own homes, it will take the pressure of the healthcare services giving people more choice over their own health.

2San says diagnostic tests became even more common during the pandemic with testing at home becoming both acceptable and appealing.

Global CEO at the company, Mark Hewlett, said: “This partnership with LloydsPharmacy is a huge step for us to enable consumers to take control over their own healthcare. Self-testing is only one part of the healthcare journey, but we believe it is an extremely important part.

“As our healthcare service continues to face increasing pressures, our partnering will enable the self-testing journey to be seamlessly linked with the appropriate treatment pathway. This excites us, as we seek to ensure people can live better, healthier lives in times of increasing pressure on healthcare systems globally.”

They commissioned research from IPSOS, a market research consulting firm and found that 87% of consumers that used COVID-19 lateral flow tests trusted the quality and outcome of test results, paving the way for 82.5% of the group surveyed welcoming the idea of being able to effectively manage aspects of their own health and wellness from home using self-tests before needing to approach the doctor.

The research also found that 91% of the 1,000 consumers who took part were happy with the process of self-diagnostic testing, and when asked what is most appealing about using self-diagnostics, the top three priorities were speed of results (29%), ability to take control of your own health (24%) and reducing the strain on NHS services (21%). All showcasing the rise in consumer demand for this type of product. 

The full tests to be launched include ones for bowel health – looking for hidden blood in stool, H.pylori ​to check for stomach ulcers, underactive thyroids, signs of drug abuse with a multi-drugs test, male fertility checking for sperm concentration, a urinary tract infection test, vaginal PH test, and a rapid strep A test. 

Related news

Show more

Related products

Pulmonary Delivery of Orally Inhaled Therapeutics

Pulmonary Delivery of Orally Inhaled Therapeutics

Content provided by Catalent Pharma Solutions | 19-Oct-2023 | Product Brochure

New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small...

Related suppliers

Follow us

Products

View more

Webinars